Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
- PMID: 29735596
- DOI: 10.1161/CIRCULATIONAHA.117.032835
Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
Comment in
-
Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)".Circulation. 2018 May 8;137(19):2087-2088. doi: 10.1161/CIRCULATIONAHA.118.033968. Circulation. 2018. PMID: 29735597 No abstract available.
Comment on
-
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).Circulation. 2017 Oct 24;136(17):1588-1597. doi: 10.1161/CIRCULATIONAHA.117.028981. Epub 2017 Oct 16. Circulation. 2017. PMID: 29038167 Free PMC article. Clinical Trial.
Similar articles
-
Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)".Circulation. 2018 May 8;137(19):2087-2088. doi: 10.1161/CIRCULATIONAHA.118.033968. Circulation. 2018. PMID: 29735597 No abstract available.
-
Letter by El-Battrawy et al Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)".Circulation. 2018 May 8;137(19):2083-2084. doi: 10.1161/CIRCULATIONAHA.117.032403. Circulation. 2018. PMID: 29735595 No abstract available.
-
BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries.Eur J Epidemiol. 2014 Oct;29(10):777-90. doi: 10.1007/s10654-014-9952-x. Epub 2014 Sep 20. Eur J Epidemiol. 2014. PMID: 25238720 Free PMC article.
-
Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation.Cardiovasc Hematol Disord Drug Targets. 2017;17(1):58-63. doi: 10.2174/1871529X17666170104120746. Cardiovasc Hematol Disord Drug Targets. 2017. PMID: 28056733 Review.
-
[Epidemiology of atrial fibrillation and relevance of underlying cardiovascular disease].Dtsch Med Wochenschr. 2006 Aug 25;131(34-35 Suppl 4):S99-102. doi: 10.1055/s-2006-949184. Dtsch Med Wochenschr. 2006. PMID: 16921450 Review. German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical